ArticleScanning2022
The Application Value of CT Three-Dimensional Microscope Reconstruction Technology in the Diagnosis of Cervical Cancer.
Article in Scanning, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
Corrections and comments
- Retraction · 2023-12-06Compromised Peer Review · Investigation by Journal/Publisher · Investigation by Third Party · Paper Mill · Unreliable Results and/or Conclusions ·
- Retracted
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In order to study the application value of CT three-dimensional microscope reconstruction technology in the diagnosis of cervical cancer. In this paper, 232 patients with newly diagnosed stage IA-II A2 and some stage III C: cervical cancer (stage IB1-IIA2 of stage f go in 2009) were selected, and 204 patients with stage IB1-IIA2 of stage 2009 fig 0 were selected. The original data of DICOM were obtained by CT scanning and imported into mics10.01 software to complete lymph node reconstruction. The short diameter value > 10 mm is used as the standard to judge whether the lymph node is metastatic. Referring to the 2018fig 0 staging standard, if it indicates that the lymph node is positive, it is IIICr stage. The gold standard is the diagnosis of III CP according to the surgical and pathological results, and then the diagnostic efficiency of III C stage is evaluated. The experimental results showed that 65 cases were diagnosed as IIIC stage, and 70 cases were diagnosed as IIICp stage. There was consistency between IIICr and IIICp stage, and the kappa value was 0.340. Using CT multiphase enhanced scanning and three-dimensional reconstruction technology to diagnose cervical cancer has high detection rate and high accuracy of staging diagnosis, which is worthy of clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.